| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Historical Data Period | 2019 - 2023 |
| CAGR | 3.00% |
Major Players
*Disclaimer: Major Players sorted in no particular order |
North America Renal Denervation Devices Market Analysis by Mordor Intelligence
The North America Renal Denervation Devices Market is expected to register a CAGR of 3% during the forecast period.
High blood pressure is called hypertension. The prevalence of hypertension has been observing a significant rise, over the past few years in North American Countries. Generally, blood pressure rises and falls throughout the day, but it can damage one's heart and result in health problems if hypertension stays high for a long time.
According to the CDC (Centers for Disease Control and Prevention), about 75 million American adults (32%) have high blood pressure (hypertension), but only about half (54%) of them, with high blood pressure, have their condition under control. High blood pressure had been the primary contributing cause of death for more than 410,000 Americans, in 2014. CDC also stated that high blood pressure costs the country USD 48.6 billion, every year. The high prevalence is not just limited to the United State, owing to the fact that the Canada and Mexico also have a high rate of hypertension.
Thus, owing to all of the aforementioned factors, the market studied is expected to witness high growth, in the coming years.
North America Renal Denervation Devices Market Trends and Insights
The Ultrasound-based Segment is Expected to be the Fastest Growing Segment
· The ultrasound-based renal denervation devices are a minimally invasive procedure, using ultrasound to ablate nerves in the wall of the renal arteries, and it disrupts the transmission of nerve impulses to and from the kidney and lowers blood pressure. Additionally, according to the first randomized trial to compare the techniques (RADIOSOUND-HTN trial), the ultrasound-based renal denervation (RDN) approach has led to greater reductions in blood pressure than radiofrequency ablation in patients, with resistant hypertension. The rising prevalence of hypertension is expected to boost the overall growth of the market studied.
· COVID-19 has negatively impacted the number of procedures and the production of the devices in North America. Due to the fear of transmission of the virus, many hospitals have canceled the procedures and the manufacturing and supply chain was disturbed due to the lockdown worldwide. Additionally, many trials and product approvals have been pending for the year, which is impacting market growth.
Understand The Key Trends Shaping This Market
Download PDF
Competitive Landscape
The North America Renal Denervation Devices Market is fragmented competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Medtronic PLC, St. Jude Medical Inc., ReCor Medical Inc., Ablative Solutions Inc., Mercator MedSystems, Terumo Corporation, Symple Surgical.
North America Renal Denervation Devices Industry Leaders
-
Medtronic PLC
-
St. Jude Medical Inc.
-
ReCor Medical Inc
-
Ablative Solutions Inc
-
Mercator MedSystems
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now
North America Renal Denervation Devices Market Report Scope
As per the scope of this report, renal denervation devices are one of several innovative device-based interventional therapies, which help to control blood pressure. It is safe, minimally invasive, and does not leave any implants behind. The market studied is segmented by technology and geography.
By Technology
| Radiofrequency-based |
| Ultrasound-based |
| Micro-infusion-based |
Geography
| North America | United States |
| Canada | |
| Mexico |
| By Technology | Radiofrequency-based | |
| Ultrasound-based | ||
| Micro-infusion-based | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
Need A Different Region or Segment?
Customize Now
Key Questions Answered in the Report
What is the current North America Renal Denervation Devices Market size?
The North America Renal Denervation Devices Market is projected to register a CAGR of 3% during the forecast period (2025-2030)
Who are the key players in North America Renal Denervation Devices Market?
Medtronic PLC, St. Jude Medical Inc., ReCor Medical Inc, Ablative Solutions Inc and Mercator MedSystems are the major companies operating in the North America Renal Denervation Devices Market.
What years does this North America Renal Denervation Devices Market cover?
The report covers the North America Renal Denervation Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the North America Renal Denervation Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Page last updated on:
North America Renal Denervation Devices Market Report
Statistics for the 2025 North America Renal Denervation Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. North America Renal Denervation Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
